Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer.

Jeong, Hyehyun; Jeong, Jae Ho; Kim, Jeong Eun; Ahn, Jin-Hee; Jung, Kyung Hae; Koh, Su-Jin; Cheon, Jaekyung; Sohn, Joohyuk; Kim, Gun Min; Lee, Keun Seok; Sim, Sung Hoon; Park, In Hae; Kim, Sung-Bae

Jeong, Hyehyun; Jeong, Jae Ho; Kim, Jeong Eun; Ahn, Jin-Hee; Jung, Kyung Hae; Koh, Su-Jin; Cheon, Jaekyung; Sohn, Joohyuk; Kim, Gun Min; Lee, Keun Seok; Sim, Sung Hoon; Park, In Hae; Kim, Sung-Bae.

Jeong H; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Jeong JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim JE; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Ahn JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Koh SJ; Division of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Ulsan, South Korea.
Cheon J; Division of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Ulsan, South Korea.
Sohn J; Department of Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Kim GM; Department of Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Lee KS; Center for Breast Cancer, National Cancer Center, Goyang, South Korea.
Sim SH; Center for Breast Cancer, National Cancer Center, Goyang, South Korea.
Park IH; Division of Medical Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.
Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.